Gerald Chi
scholar.google.com
0000-0002-8371-1689
122 papers found
Refreshing results…
Association of low hemoglobin with venous thromboembolism in acutely ill hospitalized medical patients: findings from the APEX trial
P6072 Characterization of major and clinically relevant non-major bleeding in the APEX trial
Outcome Expectations and Fibromyalgia: Perceived Benefits of Exercise Are Associated with Self-Efficacy and Physical Performance
1460 Effect of the INR stability characteristics on bleeding events among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial
4321 Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial
Abstract 16280: Betrixaban Reduced the Occurrence of Major Adverse Cardiovascular Events Among Acute Medically Ill Patients With a History of Myocardial Infarction or Stroke: Insights From the APEX Trial
Asymptomatic deep vein thrombosis in acutely ill medical patients: insights from the APEX trial
Performance of a machine learning model vs. IMPROVE score for VTE prediction in acute medically ill patients: insights from the APEX trial
P1623 Association of low hemoglobin with venous thromboembolism in acutely ill hospitalized medical patients: findings from the APEX trial
109 Betrixaban compared to enoxaparin among obese acute medically ill subjects: an APEX trial subgroup analysis
Extended-duration betrixaban reduces the risk of rehospitalization associated with venous thromboembolism among acutely ill hospitalized medical patients: findings from the APEX trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial)
Abstract 16125: Prognostic Value of C-Reactive Protein as Inflammatory Marker for Venous Thromboembolism in Acutely Ill Hospitalized Patients: Analysis From the APEX Trial
Characterization of major and clinically relevant non-major bleeding in the APEX trial
Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial
P251 Asymptomatic deep vein thrombosis in acutely ill medical patients: insights from the APEX trial
Effect of Extended Thromboprophylaxis with Non-Vitamin K Antagonist Oral Anticoagulant on the Risk of Stroke and Major Bleeding in Acutely Ill Hospitalized Medical Patients: A Meta-Analysis of Randomized Controlled Trials (S54. 001)
Effect of Extended Thromboprophylaxis with Non-Vitamin K Antagonist Oral Anticoagulant on the Risk of Stroke and Major Bleeding in Acutely Ill Hospitalized Medical Patients: A Meta-Analysis of Randomized Controlled Trials
Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial
Betrixaban compared to enoxaparin among obese acute medically ill subjects: an APEX trial subgroup analysis
Abstract 16123: D-Dimer Levels and Clinical Outcomes in Acute Coronary Syndrome Patients: An ATLAS ACS TIMI 46 Trial Substudy
Missing publications? Search for publications with a matching author name.